Efficacy and Safety of HRS-7535 Tablets in Obese Subjects .

PHASE2CompletedINTERVENTIONAL

Enrollment

235

Participants

Timeline

Start Date

February 23, 2024

Primary Completion Date

January 22, 2025

Study Completion Date

January 22, 2025

Conditions

Overweight and Obesity

Interventions

DRUG

HRS-7535;Placebo

DRUG

Placebo

Trial Locations (1)

The First Medical Center of Chinese People's Liberation Army (PLA) General Hospital, Beijing

All Listed Sponsors

lead

Shandong Suncadia Medicine Co., Ltd.

INDUSTRY

NCT06250946 - Efficacy and Safety of HRS-7535 Tablets in Obese Subjects . | Biotech Hunter | Biotech Hunter